Search

everythinglearnresearchcommunity

for

Search:↓

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Slovak breast cancer survivors have moderate quality of life, with emotional and cognitive strengths but social and physical challenges, needing targeted support.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

Pranic meditation significantly improved mental health and quality of life for breast cancer survivors.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

Resistance exercise improves body image in breast cancer survivors.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Oral minoxidil effectively improves hair regrowth in cancer survivors with late alopecia.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Spironolactone does not increase the risk of breast cancer recurrence.

Oral minoxidil may help hair regrowth in female cancer survivors.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

The BHBS is a valid tool to study cultural norms and breast cancer risk in Black women.

Breast cancer patients need strong psychological support to improve their quality of life.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Cancer survivors need better skin care to improve their quality of life.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.